Question 1

What ECG finding is most often associated with right-sided heart failure and pulmonary hypertension?

Accepted Answer

Right-axis deviation is the most common ECG finding associated with right-sided heart failure and pulmonary hypertension.

Question 2

Unless there are contraindications, what treatment is given universally to all patients with idiopathic pulmonary artery hypertension (IPAH)?

Accepted Answer

The answer of Unless there are contraindications, what treatment is...

Question 3

On average, how long does the diagnosis of idiopathic pulmonary artery hypertension (IPAH) follow the onset of the disease?

Accepted Answer

The diagnosis of idiopathic pulmonary artery hypertension (IPAH) typically follows the onset of the disease by about 2 years. This delay is often due to the nonspecific nature of early symptoms and the rarity of the condition, leading to challenges in early detection and diagnosis.

Question 4

In what type of IPAH patient is lung transplantation indicated?

Accepted Answer

Lung transplantation is indicated in patients who have advanced disease and are not responding to medical management, specifically those who have not responded to vasodilator therapy and have significant cardiac dysfunction. Lung transplantation is not indicated for all PAH patients, those with only class II disease or milder disease, or those with refractory hypoxemia.

Question 5

What therapy has been proven to improve survival in patients with COPD and pulmonary hypertension?

Accepted Answer

Oxygen therapy has been shown to improve survival in patients with COPD and pulmonary hypertension by reducing pulmonary artery pressure and improving exercise tolerance. Bronchodilators and prostanoids can improve symptoms but do not have a significant impact on survival. Oral vasodilators may be helpful in specific cases but have not been proven to improve survival in the general population with COPD and pulmonary hypertension.

Question 6

What type of drug is Bosentan?

Accepted Answer

Bosentan is an endothelin antagonist used for the treatment of pulmonary arterial hypertension. It works by blocking the action of endothelin, a substance that narrows blood vessels and contributes to the progression of pulmonary arterial hypertension.

Question 7

Idiopathic pulmonary artery hypertension (IPAH) is often a fatal disease.

Accepted Answer

Idiopathic pulmonary artery hypertension (IPAH) is a rare and progressive disease that can lead to right heart failure and death if not treated appropriately. Only a small percentage of patients survive more than 5 years without treatment.

Question 8

What is the most important factor contributing to the onset of pulmonary hypertension in the patient with COPD?

Accepted Answer

Alveolar hypoxia is the most important factor contributing to the onset of pulmonary hypertension in COPD patients. This hypoxia leads to vasoconstriction in the pulmonary artery, which in turn increases pulmonary vascular resistance and causes pulmonary hypertension. Compression of pulmonary vasculature, left ventricular failure, and loss of vascular surface can also contribute to pulmonary hypertension in COPD patients, but they are not the primary factor.

Question 9

Which of the following treatments is least useful in the treatment of the patient with idiopathic pulmonary artery hypertension?

Accepted Answer

Steroids are not useful in the treatment of idiopathic pulmonary artery hypertension as it is not an inflammatory condition. Oxygen, vasodilators (such as calcium channel blockers and endothelin receptor antagonists), and warfarin are all recommended for the treatment of idiopathic pulmonary artery hypertension.

Question 10

Lung transplantation is an option in the management of idiopathic pulmonary artery hypertension.

Accepted Answer

Lung transplantation is considered a potential treatment option in end-stage idiopathic pulmonary artery hypertension when medical treatment is no longer sufficient. It is not the first-line treatment option, but it can be an option for qualified patients who have failed medical management. Therefore, the statement presented in the question is true.

Question 11

What IV infusion has been found to improve exercise capacity, hemodynamic variables, and survival in patients with severe IPAH?

Accepted Answer

Epoprostenol has been found to improve exercise capacity, hemodynamic variables, and survival in patients with severe IPAH. Bosentan and sildenafil are oral medications used for PAH, but they do not have the same level of evidence for improving exercise capacity, hemodynamic variables, and survival in severe IPAH patients. Methylprednisolone is a steroid medication that may be used as a short-term treatment for acute exacerbations of PAH, but it is not a long-term therapy for improving exercise capacity, hemodynamic variables, and survival in severe IPAH.

Question 12

What is the 5-year survival rate for patients with untreated idiopathic pulmonary artery hypertension (IPAH)?

Accepted Answer

The 5-year survival rate for patients with untreated IPAH is approximately 33%.

Question 13

Which of the following radiographic findings is NOT typical for patients with primary pulmonary hypertension?

Accepted Answer

Pleural effusion is not a typical radiographic finding in patients with primary pulmonary hypertension. The other choices, enlargement of the pulmonary artery and right ventricle, as well as narrowing of the peripheral arteries, are commonly seen in these patients.

Question 14

Why is the use of oxygen to maintain oxygen saturations greater than 90% particularly important in the management of idiopathic pulmonary artery hypertension?

Accepted Answer

In idiopathic pulmonary artery hypertension, low alveolar oxygen levels can cause vasoconstriction, leading to increased pulmonary artery pressure and worsening of symptoms. Therefore, maintaining oxygen saturations greater than 90% is particularly important to prevent further pulmonary hypertension and improve oxygen delivery to the tissues. The other options (A, C, and D) may also be true, but they are not directly related to why oxygen saturation is important in this specific condition.

Question 15

What are the two most common symptoms associated with primary pulmonary hypertension?

Accepted Answer

Dyspnea (shortness of breath) and angina (chest pain or discomfort) are the two most common symptoms associated with primary pulmonary hypertension. Dry cough and hemoptysis (coughing up blood) may also occur, but they are less common. Syncope (fainting) and chest pain may occur in more advanced stages of the disease.

Question 16

Which of the following physical examination findings is NOT found in patients with primary pulmonary hypertension?

Accepted Answer

Digital clubbing is not typically associated with primary pulmonary hypertension. It is more commonly seen in conditions like lung cancer, cystic fibrosis, or congenital heart disease.

Question 17

What is the most important noninvasive diagnostic test for evaluation of a patient with idiopathic pulmonary artery hypertension (IPAH)?

Accepted Answer

The $\dot { V } / \dot { Q }$ scan is the most important noninvasive diagnostic test for evaluating a patient with idiopathic pulmonary artery hypertension (IPAH) because it helps exclude chronic thromboembolic pulmonary hypertension, which is a key differential diagnosis and has different treatment options.

Question 18

What ECG findings are typically seen in patients with idiopathic pulmonary artery hypertension?
I.frequent premature ventricular complexes
II.right-axis deviation
III.right ventricular hypertrophy
IV.left bundle-branch block

Accepted Answer

The typical ECG findings seen in patients with idiopathic pulmonary artery hypertension are right-axis deviation and right ventricular hypertrophy. Premature ventricular complexes and left bundle-branch block may also be present, but they are not as common or specific to this condition. Therefore, choice B is the best answer.

Question 19

Why are calcium channel blockers NOT used in all patients with idiopathic pulmonary artery hypertension?

Accepted Answer

Only a small percentage of IPAH patients respond to calcium channel blockers, so it is not a viable treatment option for all patients.

Question 20

What is the most common pulmonary function abnormality found in patients with idiopathic pulmonary artery hypertension (IPAH)?

Accepted Answer

Reduced diffusing capacity of the lungs (DLCO) is the most common pulmonary function abnormality found in patients with idiopathic pulmonary artery hypertension (IPAH). This is because the disease affects the pulmonary vasculature, leading to reduced blood flow to the lungs and impaired gas exchange, which is measured by DLCO. The other options listed are not typically affected in IPAH.

Quiz 26: Pulmonary Vascular Disease